Publizoom

TAKEDA-Farmaceuticos Portugal, Lda

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won
7
Amount won alone
€20,725,895 excl. VAT
Period
17 July 2026 – 29 September 2026

Its main clients

Where and what

Supplies · 7

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned endContractCurrent holderAmount
22 December 2026
re-tender around October 2026
2026/0098 - Velaglucerase alfa [400 u pó sol inj f/amp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
TAKEDA-Farmaceuticos Portugal, Lda
1 bid received
€11,257,384
22 December 2026
re-tender around October 2026
2026/0098 - Agalsidase alfa [1 mg/ml 3,5 ml f/amp]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
TAKEDA-Farmaceuticos Portugal, Lda
1 bid received
€1,471,097
6 January 2027
re-tender around October 2026
2023/0491 - Lanadelumab [300 mg/2 ml sol inj seringa]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
TAKEDA-Farmaceuticos Portugal, Lda
1 bid received
€1,313,954
11 January 2027
re-tender around October 2026
2023/0491 - Lanadelumab [300 mg/2 ml sol inj seringa]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
TAKEDA-Farmaceuticos Portugal, Lda
1 bid received
€3,460,080
11 January 2027
re-tender around October 2026
2023/0491 - Vedolizumab [300 mg pó conc sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
TAKEDA-Farmaceuticos Portugal, Lda
1 bid received
€970,490
11 January 2027
re-tender around October 2026
2023/0491 - Brentuximab vedotina [50 mg pó conc sol inj frs]
Unidade Local de Saúde Santa Maria, E.P.E. framework agreement
TAKEDA-Farmaceuticos Portugal, Lda
1 bid received
€424,640

Contracts won

DateContractBuyerAmount
29/09/2026 2023/0491 - Brentuximab vedotina [50 mg pó conc sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €424,640
11/08/2026 2023/0491 - Vedolizumab [300 mg pó conc sol inj frs] Unidade Local de Saúde Santa Maria, E.P.E. €970,490
11/08/2026 2026/0098 - Velaglucerase alfa [400 u pó sol inj f/amp] Unidade Local de Saúde Santa Maria, E.P.E. €11,257,384
11/08/2026 2026/0098 - Agalsidase alfa [1 mg/ml 3,5 ml f/amp] Unidade Local de Saúde Santa Maria, E.P.E. €1,471,097
28/07/2026 2023/0491 - Lanadelumab [300 mg/2 ml sol inj seringa] Unidade Local de Saúde Santa Maria, E.P.E. €1,313,954
28/07/2026 2023/0491 - Lanadelumab [300 mg/2 ml sol inj seringa] Unidade Local de Saúde Santa Maria, E.P.E. €3,460,080
17/07/2026 Rurioctocog Alfa Pegol Pó Sol Inj Fr Iv Unidade Local de Saúde de Coimbra, EPE €1,828,250

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.